Old Web
English
Sign In
Acemap
>
Paper
>
Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.
Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.
2021
Allison Portnoy
Kine Pedersen
Lill Trogstad
Bo T. Hansen
Berit Feiring
Ida Laake
Megan Smith
Stephen Sy
Mari Nygård
Jane J. Kim
Emily A. Burger
Keywords:
Actuarial science
empirical data
Current (fluid)
cost effectiveness
MEDLINE
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
0
Citations
NaN
KQI
[]